Summary: Biocon Pharma has received approval from the US Food and Drug Administration (USFDA) for…
The USFDA approves Qiagen’s QuantiFERON-TB Gold Plus Assay for use on DiaSorin’s automated Liaison XS Platform for TB Testing
KEYPOINTS: QIAGEN (QGEN) and DiaSorin said that the U.S. Food and Drug Administration has approved…
Zydus Cadila receives USFDA Final Approval for Nelarabine Injection a Therapeutically Generic Version of Arranon injection.
KEYPOINTS: Zydus Cadila has received final approval from the US FDA to market Nelarabine injection…
Alembic Pharma JV Aleor Derma Receives USFDA Approval for Mupirocin Cream a Therapeutically Generic Version of Bactroban Cream
SYNOPSIS: Alembic Pharmaceuticals Limited announced that its joint venture Aleor Dermaceuticals Limited has received final…
Antengene Receives FDA Approval of IND for Phase 1 Trial of ATG-101 (PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma.
KEYPOINTS; Antengene Corporation Limited announced that the US Food and Drug Administration (FDA) has approved…
Novartis’s BLA has been accepted by US FDA & EMA for Kymriah (Tisagenlecleucel) to treat patients with relapsed or refractory follicular lymphoma.
Novartis says that the U.S. and European regulators have accepted its marketing applications for CAR-T…
Active Pharmaceutical Ingredients (API)BictegravirEmtricitabineTenofovir Alafenamide
USFDA Approves Expanded Indication of Gilead’s Biktarvy for Treatment of HIV-1 in Pediatric Populations
Keypoints FDA Approves Low-Dose Tablet for HIV Treatment in Virologically Suppressed Children Weighing at Least…
Active Agrochemical IngredientAtezolizumab
USFDA approves Roche’s Tecentriq (Atezolizumab) as Adjuvant Treatment for Non- small Cell Lung Cancer.
Keypoints USFDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early NSCLC Tecentriq…
Keypoints J&J presented data to the 19-member committee indicating that its vaccine loses efficacy over…